MX9205637A - Metodo para prevenir el rechazo de aloinjertos. - Google Patents

Metodo para prevenir el rechazo de aloinjertos.

Info

Publication number
MX9205637A
MX9205637A MX9205637A MX9205637A MX9205637A MX 9205637 A MX9205637 A MX 9205637A MX 9205637 A MX9205637 A MX 9205637A MX 9205637 A MX9205637 A MX 9205637A MX 9205637 A MX9205637 A MX 9205637A
Authority
MX
Mexico
Prior art keywords
aloinjertos
rejection
prevent
Prior art date
Application number
MX9205637A
Other languages
English (en)
Inventor
Mitsuaki Isobe
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of MX9205637A publication Critical patent/MX9205637A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX9205637A 1991-10-01 1992-10-01 Metodo para prevenir el rechazo de aloinjertos. MX9205637A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76804491A 1991-10-01 1991-10-01

Publications (1)

Publication Number Publication Date
MX9205637A true MX9205637A (es) 1993-05-01

Family

ID=25081356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205637A MX9205637A (es) 1991-10-01 1992-10-01 Metodo para prevenir el rechazo de aloinjertos.

Country Status (8)

Country Link
EP (1) EP0610298A1 (es)
JP (1) JPH07502727A (es)
AU (1) AU667487B2 (es)
CA (1) CA2120500A1 (es)
HU (1) HUT69725A (es)
MX (1) MX9205637A (es)
WO (1) WO1993006864A1 (es)
ZA (1) ZA927503B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
ATE151642T1 (de) * 1992-02-12 1997-05-15 Biogen Inc Behandlung für entzündungserkrankung des darmes
WO1994004188A1 (en) * 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
US5817515A (en) * 1993-12-23 1998-10-06 Icos Corporation Human B2 integrin alpha subunit antibodies
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
AU2001230920A1 (en) * 2000-01-14 2001-07-24 Genentech Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
CA2454618C (en) 2001-07-24 2012-04-03 Biogen Idec Ma, Inc. Methods for treating or preventing sclerotic disorders using cd2-binding agents
WO2005115436A1 (en) 2004-05-07 2005-12-08 Astellas Us Llc Soluble lfa-3 polypeptide for treating viral disorders
AU2005254980A1 (en) 2004-06-09 2005-12-29 Genentech, Inc. Method of treating granuloma annulare or sarcoid
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852374T2 (de) * 1987-11-02 1995-05-04 Baylor College Medicine Verwendung von ICAM-1 oder ihre funktionelle Derivate zur Behandlung unspezifischer Entzündungen.
ATE246245T1 (de) * 1988-09-28 2003-08-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden
ATE142505T1 (de) * 1988-11-14 1996-09-15 Brigham & Womens Hospital Antikörper, spezifisch gegen elam-1 sowie deren verwendung
EP0387701B1 (en) * 1989-03-09 1992-08-12 Boehringer Ingelheim Pharmaceuticals Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
AU5553290A (en) * 1989-04-28 1990-11-29 Baylor College Of Medicine Dissemination of hiv-1 infected cells
US5011778A (en) * 1989-05-23 1991-04-30 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
GB9009549D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method

Also Published As

Publication number Publication date
EP0610298A1 (en) 1994-08-17
AU667487B2 (en) 1996-03-28
ZA927503B (en) 1993-05-03
AU2782992A (en) 1993-05-03
HUT69725A (en) 1995-09-28
CA2120500A1 (en) 1993-04-15
JPH07502727A (ja) 1995-03-23
WO1993006864A1 (en) 1993-04-15
HU9400930D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
MX9203870A (es) Metodo para la produccion de granulos.
ES2023976B3 (es) Procedimiento para el enriquecimiento de helio.
FI924202A0 (fi) Anordning vid fordon.
MX9207008A (es) Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
FI910499A (fi) Lekredskap foer anvaendning vid bollspel.
FI915658A0 (fi) Torkdel vid pappersmaskiner.
MX9205637A (es) Metodo para prevenir el rechazo de aloinjertos.
MX9203919A (es) Procedimiento para purificar organopolisiloxanos.
FI900688A0 (fi) Anordning foer luftning av liggunderlag i sjuksaeng.
DE69100071T2 (de) Käfigmutter.
MX9205285A (es) Alojamiento para colocar piezas de trabajo para maquinado y metodo para fabricar y separar el alojamiento.
FI894921A0 (fi) Anordning foer foertunnande av kanten vid en kartongbana eller -ark.
MX9200528A (es) Metodo para acortar el tiempo de acceso.
FR2657403B1 (fr) Ecrou anti-jeu.
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
FI904509A0 (fi) Bankkonstruktion vid virkestransportbil.
FI912529A (fi) Saett vid kloratframstaellning.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
FI921634A0 (fi) Med elkraft el producerande kraftverk och -maskin.
FI902172A0 (fi) Haenganordning med killaosning foer placering pao staoltraod.
FI895310A0 (fi) Foerfarande vid raostyckning av en kropp.
ES1017890Y (es) Dispositivo para el tratamiento de uneros.
ES1022662Y (es) Dispositivo para la utilizacion de bicicletas convencionales como bicicletas estaticas.
ES1004803Y (es) Dispositivo para el montaje de cercas para piscicultura.
ES1017081Y (es) Elemento de soporte para la configuracion de cercados o similares.